As of 12:31 PM on the 29th, Humasis is trading at 10,400 KRW, the same price as the previous day. This represents a 226.53% increase compared to June 9. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 360,923 shares, while foreign investors and institutions have net sold 131,034 shares and 244,588 shares, respectively.
On June 25, Humasis became a market issue with the headline "Plunges to lower limit after 6 consecutive gains."
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
